An interventional study of Home-based therapy and Standard Care (in control arm) in Benign Paroxysmal Positional Vertigo (BPPV) and Vestibular Hypofunction, sponsored by Muhammad Hizami bin Mustafa. Active, not recruiting at 1 site in Malaysia. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-08-05.
Sponsored by Muhammad Hizami bin Mustafa · Not applicable, Interventional, and Treatment
The goal of this feasibility pilot randomised controlled trial is to determine whether a home-based exercise programme integrated with a self-managed education programme is feasible, acceptable, and safe for adults aged 60 years and older with benign paroxysmal positional vertigo (BPPV) with and without vestibular hypofunction. The study will also evaluate whether the trial procedures are suitable for a future definitive randomised controlled trial.
The main questions it aims to answer are:
Can participants follow the programme as planned? Can participants be retained throughout the 20-week study? Is the programme acceptable to participants? Do participants experience any adverse events? Do the clinical outcomes show preliminary changes that support further investigation?
Researchers will randomly assign participants to receive either the home-based exercise and self-managed education programme or standard care alone. Preliminary changes in dizziness, balance confidence, gait performance, fall risk, physical activity, and health-related quality of life will be explored. As this is a feasibility pilot study, it is not designed to provide definitive evidence of effectiveness.
Participants will:
Take part in the study for 20 weeks Follow their assigned intervention or standard care as instructed Complete assessments at baseline, week 10, and week 20 Report their adherence, experience with the programme, and any adverse events during the study
73 studies on the registry are indexed under Benign Paroxysmal Positional Vertigo; 15 are open to participants now.
This study's enrollment of 30 is below the median of 75 across 59 interventional studies indexed under Benign Paroxysmal Positional Vertigo.
Browse Benign Paroxysmal Positional Vertigo studies →This is the only study on the registry with Muhammad Hizami bin Mustafa as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Home-based therapy
Other: Standard Care (in control arm)
The intervention combines structured, progressive home-based exercises with a self-managed education resource. The exercises are based on vestibular rehabilitation principles and target movement-related dizziness, gaze stability, postural balance, gait, and functional mobility. Participants receive an illustrated booklet containing step-by-step exercise instructions, guidance on gradual progression and rest periods, and safety precautions. Exercise progression is adapted according to the participant's functional ability and symptom response. The education component addresses understanding of BPPV and vestibular hypofunction, safe exercise performance, symptom self-management, adherence, and when to seek professional advice. Participants are instructed to discontinue an exercise and obtain appropriate clinical advice if severe or worsening symptoms occur.
Standard care consists of routine clinical management for BPPV with and without vestibular hypofunction provided at the study site. Treatment includes a canalith repositioning manoeuvre selected according to the affected semicircular canal and side, together with routine clinical advice and follow-up. Any additional management is determined by the treating clinician according to the participant's clinical needs and usual practice at the study site.
The Activities-specific Balance Confidence Scale
Time frame: From enrollment to the end of treatment at 20 weeks
Dizziness Handicap Inventory
Time frame: From enrollment to the end of treatment at 20 weeks
Dynamic Gait Index
Time frame: From enrollment to the end of treatment at 20 weeks
Timed Up and Go
Time frame: From enrollment to the end of treatment at 20 weeks
5 Times Sit To Stand
Time frame: From enrollment to the end of treatment at 8 weeks
EQ-5D-5L
Time frame: From enrollment to the end of treatment at 8 weeks
Plan to share: No — Individual participant data will not be shared because external sharing of participant-level data is not included in the ethics-approved data-management plan or participant consent process. Furthermore, the small, single-site sample and detailed clinical information may increase the risk of participant re-identification, even after de-identification. Study findings will be disseminated only in aggregated form through scientific publications and presentations.
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Benign Paroxysmal Positional Vertigo→